Effects of unmeasured heterogeneity in the linear transformation model for censored data
From MaRDI portal
Publication:849905
DOI10.1007/S10985-006-9008-YzbMATH Open1134.62368OpenAlexW2130787269WikidataQ31047773 ScholiaQ31047773MaRDI QIDQ849905FDOQ849905
Authors: Bin Zhang, Yi Li, Rebecca A. Betensky 
Publication date: 15 November 2006
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10985-006-9008-y
Recommendations
- Effect of Frailty on Marginal Regression Estimates in Survival Analysis
- The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power
- Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
- A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials
- scientific article; zbMATH DE number 124958
Censored data models (62N01) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cites Work
- Analysis of transformation models with censored data
- Robust inference for univariate proportional hazards frailty regression models
- Title not available (Why is that?)
- Effect of misspecification of regression models in the analysis of survival data
- Properties of Proportional-Hazards Score Tests under Misspecified Regression Models
- Consistency of the NPML Estimator in the Right-Censored Transformation Model
- Efficient semiparametric estimators via modified profile likelihood
- The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power
Cited In (5)
- Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
- The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power
- The effect of treatment delay on time-to-recovery in the presence of unobserved heterogeneity
- Designed extension of survival studies: application to clinical trials with unrecognized hetero\-ge\-neity
- Erratum to: ``Effects of unmeasured heterogeneity in the linear transformation model for censored data
This page was built for publication: Effects of unmeasured heterogeneity in the linear transformation model for censored data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q849905)
